Doosan Mobility Innovation (DMI) announced on March 30 that it has signed a partnership with the Massachusetts Institute of Technology's Electric Vehicle Team (MIT EVT) to jointly develop motorcycles powered by hydrogen fuel cells.The hydrogen motorcycle to be developed by the two sides this tim
The author is an analyst of KB Securities. He can be reached at kimtaehee@kbfg.com. -- Ed.Maintain BUY; Revising up TP to KRW380,000 We maintain BUY on Hanmi Pharm but raise our TP from KRW350,000 to KRW380,000 upon changes to 2023E equity risk premium (5.41%) and risk-free rate (3.32%) as well as s
The authors are analysts of Shinhan Investment Corp. They can be reached at doyeon@shinhan.com and hyon@shinhan.com, respectively. – Ed. More time needed for market conditions to recover; focus to shift to supply cuts In our recent reports, we reviewed semiconductor market conditions and share price
SK Group will invest 67 trillion won in non-capital regions over the next five years, the group announced on Sept. 14.SK Group announced its investment and R&D plans to enhance the domestic infrastructure and technological competitiveness of the so-called BBC industries -- batteries, biotech and chi
SK Hynix will build a new semiconductor production plant, dubbed M15X, in Cheongju, North Chungcheong Province, by investing over 15 trillion won.The company announced on Sept. 6 that it has decided to start construction of M15X, an expansion fab of the M15 NAND flash production line ahead of schedu
The author is an analyst of NH Investment & Securities. He can be reached at hwdoh@nhqv.com. -- Ed. New investment for memory chips is likely to decline until 1H23 due to a slowdown in memory chip supply-demand conditions. However, SEC’s foundry business is expected to continue expanding its investm
Hanmi Pharmaceutical has risen to the top in the Korean orphan drug industry. The company has a total of 17 drugs that have been designated as orphan drugs in the United States, Europe and Korea.The company invests about 20 percent of its sales revenue, earned through the sales of drugs developed in
Hanmi Pharmaceutical's new bio drug LAPSTriple Agonist (HM15211) has been additionally designated as an orphan drug for idiopathic pulmonary fibrosis (IPF) by the U.S. Food and Drug Administration, the company announced on May 12 (U.S. local time).Earlier LAPSTriple Agonist was designated as a d
Hanmi Pharmaceutical announced on Sept. 25 that it presented the results of three studies on potential first-in-class nonalcoholic steatohepatitis (NASH) treatment LAPSTriple Agonist (HM15211) and two studies on first-in-class obesity treatment LAPSglucagon Analog (HM15136) in the 56th meeting of th
Hanmi Pharmaceutical announced on Aug. 18 that it will announce the results of its clinical trial and pre-clinical trial research on LAPSTriple Agonist (HM15211) at the International Liver Congress of the European Association for the Study of the Liver (EASL), which will be held online from Aug.27-2
The author is an analyst of NH Investment & Securities. He can be reached at william.ku@nhqv.com. -- Ed. Hanmi Pharm has inked a US market licensing-out contract with MSD for HM12525A. While we favorably view recovery in the value of a pipeline drug that was returned from Janssen, this positive look
Hanmi Pharmaceutical announced on June 30 that the U.S. Food and Drug Administration (FDA) has designated its short bowel syndrome drug LAPSGLP-2 Analog (code name: HM15912) as a rare pediatric disease (RPD) medication.Hanmi Pharmaceutical is conducting the first-phase clinical trial for the medicat
The authors are analysts of Shinhan Investment Corp. They can be reached at johnsoh@shinhan.com and chank@shinhan.com, respectively. -- Ed. 2020 sales forecast at KRW925.7bn (+19.9% YoY)For 2Q20, SK Materials is expected to report earnings improvement on increased capacity utilization of semiconduct
The author is an analyst of NH Investment & Securities. He can be reached at william.ku@nhqv.com. -- Ed. Sanofi returns Efpeglenatide rights; only Spectrum and Genentech remain as partnersDue to Sanofi’s returning of rights for Efpeglenatide, the drug is excluded from our calculation of Hanmi Pharm’
Although NAND flash prices have rebounded since the start of the second half, the upward momentum is unlikely to continue due to a sluggish demand recovery, industry experts say. In addition, concern is raised over a supply glut next year due to massive investments by NAND flash makers such as Samsu
SK Hynix Inc., the world’s second-largest memory chipmaker, has completed the expansion of its dynamic random-access memory (DRAM) manufacturing plant in Wuxi, China.SK Hynix held a completion ceremony for C2F, an expansion of its existing C2 DRAM fabrication line in Wuxi, Jiangsu Province of China,
SK Hynix Inc. will build liquefied natural gas (LNG)-based thermal power plants to supply electricity for its semiconductor production facilities.The company announced on March 4 that it will construct its own power generating facility “Smart Energy Center” near its semiconductor plants in Icheon, G
SK Hynix has submitted a letter of intent to Yongin City, Gyeonggi Province, disclosing its intention to create a semiconductor cluster by investing 120 trillion won (US$106.5 billion).The letter, which was sent to the city government on Feb. 21, demonstrated the company’s intention not be swayed by
The Korean government is pushing for a large-scale semiconductor cluster consisting of four semiconductor manufacturing plants and production facilities of some 50 parts and equipment companies.SK Hynix is reportedly considering building a new semiconductor plant in the cluster, where the governme
Both Samsung Electronics and SK Hynix are making huge investments to keep way ahead of the others in the global semiconductor industry. The two companies’ combined capital expenditure for this year is close to half of that of the global top five and one-third of the total capital expenditure in the